C

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Watchlist Manager
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Watchlist
Price: 2.29 HKD 0.44% Market Closed
Market Cap: 11.5B HKD
Have any thoughts about
China Traditional Chinese Medicine Holdings Co Ltd?
Write Note

China Traditional Chinese Medicine Holdings Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China Traditional Chinese Medicine Holdings Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Accounts Payable
ÂĄ9.1B
CAGR 3-Years
59%
CAGR 5-Years
37%
CAGR 10-Years
53%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Accounts Payable
HK$3.5B
CAGR 3-Years
63%
CAGR 5-Years
38%
CAGR 10-Years
20%
U
United Laboratories International Holdings Ltd
HKEX:3933
Accounts Payable
ÂĄ5.3B
CAGR 3-Years
27%
CAGR 5-Years
16%
CAGR 10-Years
6%
Sino Biopharmaceutical Ltd
HKEX:1177
Accounts Payable
ÂĄ2.2B
CAGR 3-Years
10%
CAGR 5-Years
-2%
CAGR 10-Years
18%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Accounts Payable
HK$141.9B
CAGR 3-Years
41%
CAGR 5-Years
27%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Accounts Payable
$43.4m
CAGR 3-Years
15%
CAGR 5-Years
11%
CAGR 10-Years
4%
No Stocks Found

China Traditional Chinese Medicine Holdings Co Ltd
Glance View

Market Cap
11.5B HKD
Industry
Pharmaceuticals

China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.

Intrinsic Value
4.12 HKD
Undervaluation 44%
Intrinsic Value
Price
C

See Also

What is China Traditional Chinese Medicine Holdings Co Ltd's Accounts Payable?
Accounts Payable
9.1B CNY

Based on the financial report for Jun 30, 2024, China Traditional Chinese Medicine Holdings Co Ltd's Accounts Payable amounts to 9.1B CNY.

What is China Traditional Chinese Medicine Holdings Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
53%

Over the last year, the Accounts Payable growth was 281%. The average annual Accounts Payable growth rates for China Traditional Chinese Medicine Holdings Co Ltd have been 59% over the past three years , 37% over the past five years , and 53% over the past ten years .

Back to Top